title: World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA.
abstract: The World Antibody-Drug Conjugate (WADC) Summits organized by Hanson Wade are currently the largest meetings fully dedicated to ADCs. The first global ADC Summit was organized in Boston in October 2010. Since 2011, two WADC are held every year in Frankfurt and San Francisco, respectively. The 2013 WADC San Francisco event was structured around plenary sessions with keynote speakers from AbbVie, Agensys, ImmunoGen, Immunomedics, Genentech, Pfizer and Seattle Genetics. Parallel tracks were also organized addressing ADC discovery, development and optimization of chemistry, manufacturing and control (CMC) issues. Discovery and process scientists, regulatory experts (US Food and Drug Administration), academics and clinicians were present, including representatives from biotechnology firms (Concortis, CytomX Therapeutics, Glykos, Evonik, Igenica, Innate Pharma, Mersana Therapeutics, Polytherics, Quanta Biodesign, Redwood Bioscience, Sutro Biopharma, SynAffix), pharmaceutical companies (Amgen, Genmab, Johnson and Johnson, MedImmune, Novartis, Progenics, Takeda) and contract research or manufacturing organizations (Baxter, Bayer, BSP Pharmaceuticals, Fujifilm/Diosynth, Lonza, Pierre Fabre Contract Manufacturing, Piramal, SAFC, SafeBridge).
authors.affiliation: Centre d'Immunologie Pierre Fabre; Saint Julien en Genevois, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Klinguer-Hamour
authors.affiliation: Rinat-Pfizer; South San Francisco, CA USA.
authors.forename: Pavel
authors.initials: P
authors.lastname: Strop
authors.affiliation: Department of Pharmaceutical Sciences; The State University of New York at Buffalo; Buffalo, NY USA.
authors.forename: Dhaval K
authors.initials: DK
authors.lastname: Shah
authors.affiliation: Lonza; Visp, Switzerland.
authors.forename: Laurent
authors.initials: L
authors.lastname: Ducry
authors.affiliation: Pfizer; Pearl River, NY USA.
authors.forename: April
authors.initials: A
authors.lastname: Xu
authors.affiliation: Centre d'Immunologie Pierre Fabre; Saint Julien en Genevois, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Beck
mesh_terms: D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003226:Congresses as Topic; D017277:Drug Approval; D016503:Drug Delivery Systems; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D018796:Immunoconjugates